Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600513.SS

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 175.57 M

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Current Liabilities is USD 175.57 M for the year ending December 31, 2023, a -2.59% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 180.24 M, a 12.58% change year over year.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 160.11 M, a 26.98% change year over year.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 126.09 M, a 15.75% change year over year.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 108.93 M, a 58.25% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shanghai Stock Exchange: 600513.SS

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

CEO	Mr. Ben Niu
IPO Date	March 19, 2003
Location	China
Headquarters	No. 9 Jiankangyi Road
Employees	1,296
Sector	Consumers Staples
Industries Cleaning Supplies Chemicals & Advanced Materials Cosmetics Fertilizers Personal Care Petrochemicals Pharmaceuticals Plastics

Description

Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers cardiovascular, anti-allergic, urinary, anti-infective, and immunomodulatory products. The company was founded in 2000 and is headquartered in Yangzhou, China.

Key trends

Past 5 years